Protein biomarker discovery and validation: the long and uncertain path to clinical utility

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965 · see citing works

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Akufo and Ibarapa

Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917 · see citing works

Practical Statistics for Medical Research.

Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,665 · see citing works

Mass spectrometry-based proteomics

Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955 · see citing works

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine

ZWEIG, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,528 · see citing works

Practical Statistics for Medical Research.

Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,834 · see citing works

The Human Plasma Proteome

Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414 · see citing works

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101 · see citing works

Use of proteomic patterns in serum to identify ovarian cancer

Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236 · see citing works

Printing Proteins as Microarrays for High-Throughput Function Determination

MacBeath, G., & Schreiber, S. L. (2000) · Science · doi:10.1126/science.289.5485.1760 · Cited by 2,767 · see citing works

Tietz Textbook of Clinical Chemistry

(1999) · Archives of Pathology & Laboratory Medicine · doi:10.5858/123.7.646b · Cited by 2,518 · see citing works

Tietz Textbook of Clinical Chemistry and Molecular Diagnostics

Burtis, E. B. C. A., Ashwood, E. R., & Bruns, D. E. (2011) · Medical Entomology and Zoology · Cited by 2,190 · see citing works

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832254100 · Cited by 1,733 · see citing works

Nomenclature in evaluation of analytical methods including detection and quantification capabilities (IUPAC Recommendations 1995)

Currie, L. A. (1995) · Pure and Applied Chemistry · doi:10.1351/pac199567101699 · Cited by 1,716 · see citing works

Mass spectrometry–based proteomics turns quantitative

Ong, S.-E., & Mann, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio736 · Cited by 1,572 · see citing works

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230 · see citing works

The case for early detection

Etzioni, R., Urban, N. D., Ramsey, S. D., McIntosh, M. W., Schwartz, S., Reid, B. J., Radich, J. P., Anderson, G. L., & Hartwell, L. H. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1041 · Cited by 1,171 · see citing works

The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration

Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P., Irwig, L., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Clinical Chemistry · doi:10.1373/49.1.7 · Cited by 1,124 · see citing works

Role of Accurate Mass Measurement (±10 ppm) in Protein Identification Strategies Employing MS or MS/MS and Database Searching

Clauser, K. R., Baker, P. R., & Burlingame, A. L. (1999) · Analytical Chemistry · doi:10.1021/ac9810516 · Cited by 1,084 · see citing works

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert‐Buck, M. R., Roth, M. J., Petricoin, E. F., & Liotta, L. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204265 · Cited by 956 · see citing works

Metabolite profiling: from diagnostics to systems biology

Fernie, A. R., Trethewey, R. N., Krotzky, A. J., & Willmitzer, L. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1451 · Cited by 847 · see citing works

Characterization of the Low Molecular Weight Human Serum Proteome

Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 846 · see citing works

Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)

Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 806 · see citing works

Toward a Human Blood Serum Proteome

Adkins, J., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., & Pounds, J. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200066-mcp200 · Cited by 788 · see citing works

Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database

Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787 · see citing works

Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C. H., Antman, E. M., Cannon, C. P., & D, E. B. M. (2002) · Circulation · doi:10.1161/01.cir.0000015464.18023.0a · Cited by 733 · see citing works

Evidence base of clinical diagnosis: The architecture of diagnostic research

Sackett, D. L. (2002) · BMJ · doi:10.1136/bmj.324.7336.539 · Cited by 724 · see citing works

Multiplexed protein measurement: technologies and applications of protein and antibody arrays

Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 717 · see citing works

Tietz Textbook of Clinical Chemistry

David (1994) · JAMA · doi:10.1001/jama.1994.03520080086056 · Cited by 707 · see citing works

Quantification of Proteins and Metabolites by Mass Spectrometry without Isotopic Labeling or Spiked Standards

Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S. M., Kumar, P., Anderle, M., & Becker, C. H. (2003) · Analytical Chemistry · doi:10.1021/ac026468x · Cited by 654 · see citing works

Antibody arrays for high-throughput screening of antibody–antigen interactions

de Wildt, R. M. T., Mundy, C. R., Gorick, B. D., & Tomlinson, I. M. (2000) · Nature Biotechnology · doi:10.1038/79494 · Cited by 625 · see citing works

Human Anti-Animal Antibody Interferences in Immunological Assays

Kricka, L. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.942 · Cited by 589 · see citing works

Autoantibody Signatures in Prostate Cancer

Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D. A., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051931 · Cited by 583 · see citing works

The Differential Effects of Mutant <i>p53</i> Alleles on Advanced Murine Lung Cancer

Jackson, E. L., Olive, K. P., Tuveson, D. A., Bronson, R., Crowley, D., Brown, M., & Jacks, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2193 · Cited by 553 · see citing works

Clinical proteomics: translating benchside promise into bedside reality

Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd891 · Cited by 545 · see citing works

Untitled work

(2003) · PubMed · Cited by 523 · see citing works

The Need for Guidelines in Publication of Peptide and Protein Identification Data

Carr, S. A., Aebersold, R. H., Baldwin, M. A., Burlingame, A. L., Clauser, K. R., & Nesvizhskii, A. I. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t400006-mcp200 · Cited by 500 · see citing works

The Immunoassay Handbook

(2013) · Elsevier eBooks · doi:10.1016/c2010-0-66244-4 · Cited by 484 · see citing works

Serum protein markers for early detection of ovarian cancer

Mor, G., Visintin, I., Lai, Y., Zhao, H., Schwartz, P. E., Rutherford, T., Yue, L., Bray‐Ward, P., & Ward, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502178102 · Cited by 482 · see citing works

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

Nishizuka, S., Charboneau, L., Young, L., Major, S. M., Reinhold, W. C., Waltham, M. C., Kouros‐Mehr, H., Bussey, K. J., Lee, J. K., Espina, V. A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331323100 · Cited by 474 · see citing works

Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia

Sabatine, M. S., Liu, E. H., Morrow, D. A., Heller, E., McCarroll, R. M., Wiegand, R. C., Berriz, G. F., Roth, F. P., & Gerszten, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.569137 · Cited by 461 · see citing works

Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass Spectrometry

Villanueva, J., Philip, J., Entenberg, D. R., Chaparro, C. A., Tanwar, M. K., Holland, E. C., & Tempst, P. (2004) · Analytical Chemistry · doi:10.1021/ac0352171 · Cited by 447 · see citing works

Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome

Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 422 · see citing works

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects

Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Price, N., Dinges, D. F., & Mullington, J. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.426 · Cited by 410 · see citing works

Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book

Sadygov, R. G., Cociorva, D., & Yates, J. R. (2004) · Nature Methods · doi:10.1038/nmeth725 · Cited by 409 · see citing works

European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials

Apple, F. S., Wu, A. H. B., & Jaffe, A. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124048 · Cited by 402 · see citing works

Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards

Kuhn, E. W., Wu, J., Karl, J., Liao, H., Zolg, W., & Guild, B. (2004) · PROTEOMICS · doi:10.1002/pmic.200300670 · Cited by 398 · see citing works

Protein Identification at the Low Femtomole Level from Silver-Stained Gels Using a New Fritless Electrospray Interface for Liquid Chromatography–Microspray and Nanospray Mass Spectrometry

Gatlin, C. L., Kleemann, G. R., Hays, L. G., Link, A. J., & Yates, J. R. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2809 · Cited by 392 · see citing works

On dividing reference data into subgroups to produce separate reference ranges

Harris, E. K., & Boyd, J. C. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.2.265 · Cited by 380 · see citing works

ROC Curves in Clinical Chemistry: Uses, Misuses, and Possible Solutions

Obuchowski, N. A., Lieber, M. L., & Wians, F. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031823 · Cited by 358 · see citing works

“Of mice and men”

Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352 · see citing works

Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I

Barr, J. R., Maggio, V. L., Patterson, D. G., Cooper, G. R., Henderson, L. O., Turner, W. E., Smith, S. J., Hannon, W. H., Needham, L. L., & Sampson, E. J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.10.1676 · Cited by 347 · see citing works

Evaluation of regression procedures for methods comparison studies

Línnet, K. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.3.424 · Cited by 324 · see citing works

Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D., Eng, J. K., Speicher, D. W., & Hanash, S. (2006) · Nature Biotechnology · doi:10.1038/nbt1183 · Cited by 318 · see citing works

Improved peptide identification in proteomics by two consecutive stages of mass spectrometric fragmentation

Olsen, J. V., & Mann, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405549101 · Cited by 314 · see citing works

Advances in proteomics data analysis and display using an accurate mass and time tag approach

Zimmer, J. S. D., Monroe, M. E., Qian, W., & Smith, R. D. (2006) · Mass Spectrometry Reviews · doi:10.1002/mas.20071 · Cited by 305 · see citing works

Proteomic Characterization of the Interstitial Fluid Perfusing the Breast Tumor Microenvironment

Celis, J. E., Gromov, P., Cabezón, T., Moreira, J. M. A., Ambartsumian, N. S., Sandelin, K., Rank, F. E., & Gromova, I. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400009-mcp200 · Cited by 305 · see citing works

Heterophilic antibodies: a problem for all immunoassays.

Boscato, L. M., & Stuart, M. C. A. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.1.27 · Cited by 301 · see citing works

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

Rosty, C., Christa, L., Kuzdzal, S. A., Baldwin, W. M., ZAHURAK, M. L., Carnot, F., Chan, D. W., Canto, M. I., Lillemoe, K. D., Cameron, J. L., et al. (2002) · PubMed · Cited by 292 · see citing works

Ultra-High-Efficiency Strong Cation Exchange LC/RPLC/MS/MS for High Dynamic Range Characterization of the Human Plasma Proteome

Shen, Y., Jacobs, J., Camp, D., Fang, R., Moore, R., Smith, R. D., Xiao, W., Davis, R. W., & Tompkins, R. G. (2004) · Analytical Chemistry · doi:10.1021/ac034869m · Cited by 290 · see citing works

Principles and Practice of Immunoassay

Price, C. P., & Newman, D. J. (1991) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-11234-0 · Cited by 256 · see citing works

Absolute Quantification of the Model Biomarker Prostate-Specific Antigen in Serum by LC−MS/MS Using Protein Cleavage and Isotope Dilution Mass Spectrometry

Barnidge, D. R., Goodmanson, M. K., Klee, G. G., & Muddiman, D. C. (2004) · Journal of Proteome Research · doi:10.1021/pr049963d · Cited by 253 · see citing works

Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment

Ledue, T. B., & Rifai, N. (2003) · Clinical Chemistry · doi:10.1373/49.8.1258 · Cited by 241 · see citing works

Statistical Bases of Reference Values in Laboratory Medicine

Harris, E. K., & Boyd, J. C. (1995) · CRC Press eBooks · doi:10.1201/9781482273151 · Cited by 235 · see citing works

Protein Identification by Mass Spectrometry

Baldwin, M. A. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r300012-mcp200 · Cited by 230 · see citing works

International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values.

Solberg, H. E. (1987) · PubMed · Cited by 210 · see citing works

LC/MS applications in drug development.

Lee, M. S., & Kerns, E. H. (1999) · PubMed · doi:10.1002/(sici)1098-2787(1999)18:3/4 · Cited by 207 · see citing works

Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation

Rifai, N., & Ridker, P. M. (2003) · Clinical Chemistry · doi:10.1373/49.4.666 · Cited by 199 · see citing works

Analytical performance characteristics should be judged against objective quality specifications

Fraser, C. G., & Petersen, P. H. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.3.321 · Cited by 194 · see citing works

Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System

Liu, M. Y., Xydakis, A. M., Hoogeveen, R. C., Jones, P. H., Smith, E. O., Nelson, K. W., & Ballantyne, C. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.047084 · Cited by 179 · see citing works

The US Food and Drug Administration perspective on cancer biomarker development

Gutman, S. I., & Kessler, L. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1911 · Cited by 176 · see citing works

Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS

Nesvizhskii, A. I., & Aebersold, R. H. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02978-7 · Cited by 173 · see citing works

The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits.

Solberg, H. E. (1983) · PubMed · Cited by 167 · see citing works

Proteomics: From Basic Research to Diagnostic Application. A Review of Requirements & Needs

Vitzthum, F., Behrens, F., Anderson, N. L., & Shaw, J. H. (2005) · Journal of Proteome Research · doi:10.1021/pr050080b · Cited by 165 · see citing works

Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue

Desiderio, D. M., & Kai, M. (1983) · Journal of Mass Spectrometry · doi:10.1002/bms.1200100806 · Cited by 158 · see citing works

Carcinogenesis in mouse and human cells: parallels and paradoxes

Balmain, A., & Harris, C. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.371 · Cited by 154 · see citing works

On the use and computation of likelihood ratios in clinical chemistry.

Albert, A. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.5.1113 · Cited by 152 · see citing works

Tandem mass spectrometry (MS/MS) instrumentation

Yost, R. A., & Fetterolf, D. D. (1983) · Mass Spectrometry Reviews · doi:10.1002/mas.1280020102 · Cited by 148 · see citing works

Nocturnal plasma levels of cytokines in healthy men

Gudewill, S., Pollmächer, T., Vedder, H., Schreiber, W., Fassbender, K. C., & Holsboer, F. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190343 · Cited by 145 · see citing works

Evidence base of clinical diagnosis: The architecture of diagnostic research

Sackett, D. L., & Haynes, R. B. (2002) · doi:10.3760/cma.j.issn.1007-9742.2003.03.130 · Cited by 143 · see citing works

De novo sequencing, peptide composition analysis, and composition-based sequencing: A new strategy employing accurate mass determination by fourier transform ion cyclotron resonance mass spectrometry

Spengler, B. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2004.01.007 · Cited by 138 · see citing works

Integrating “Top-Down” and “Bottom-Up” Mass Spectrometric Approaches for Proteomic Analysis of Shewanella oneidensis

VerBerkmoes, N. C., Bundy, J. L., Hauser, L., Asano, K. G., Razumovskaya, J., Larimer, F. W., Hettich, R. L., & Stephenson, J. L. (2002) · Journal of Proteome Research · doi:10.1021/pr025508a · Cited by 131 · see citing works

Statistical Models for Protein Validation Using Tandem Mass Spectral Data and Protein Amino Acid Sequence Databases

Sadygov, R. G., Liu, H., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac035112y · Cited by 127 · see citing works

Informatics for protein identification by mass spectrometry

Johnson, R. S., Davis, M. T., Taylor, J. A., & Patterson, S. D. (2005) · Methods · doi:10.1016/j.ymeth.2004.08.014 · Cited by 125 · see citing works

De novo sequencing, peptide composition analysis, and composition-based sequencing: a new strategy employing accurate mass determination by fourier transform ion cyclotron resonance mass spectrometry

Spengler, B. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(04)00073-x · Cited by 124 · see citing works

Targeted Proteomics of Low-Level Proteins in Human Plasma by LC/MSn: Using Human Growth Hormone as a Model System

Wu, S., Amato, H., Biringer, R. G., Choudhary, G., Shieh, P., & Hancock, W. S. (2002) · Journal of Proteome Research · doi:10.1021/pr025537l · Cited by 123 · see citing works

The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics

Anderson, N. L. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.i500001-mcp200 · Cited by 120 · see citing works

Diagnostics and biomarker development: priming the pipeline

Phillips, K. A., Bebber, S. L. V., & Issa, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2033 · Cited by 118 · see citing works

MapQuant: Open‐source software for large‐scale protein quantification

Leptos, K. C., Sarracino, D. A., Jaffe, J. D., Krastins, B., & Church, G. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500201 · Cited by 114 · see citing works

Array‐based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer

Gulmann, C., Sheehan, K. M., Kay, E., Liotta, L. A., & Petricoin, E. (2006) · The Journal of Pathology · doi:10.1002/path.1958 · Cited by 108 · see citing works

Structural elucidation of drug metabolites by triple-quadrupole mass spectrometry

Perchalski, R. J., Yost, R. A., & Wilder, B. J. (1982) · Analytical Chemistry · doi:10.1021/ac00246a006 · Cited by 101 · see citing works

High-Efficiency On-Line Solid-Phase Extraction Coupling to 15−150-μm-i.d. Column Liquid Chromatography for Proteomic Analysis

Shen, Y., Moore, R. J., Zhao, R., Blonder, J., Auberry, D. L., Masselon, C., Paša‐Tolić, L., Hixson, K. K., Auberry, K. J., & Smith, R. D. (2003) · Analytical Chemistry · doi:10.1021/ac0300690 · Cited by 97 · see citing works

Place of Pattern in Proteomic Biomarker Discovery

Gillette, M. A., Mani, D. R., & Carr, S. A. (2005) · Journal of Proteome Research · doi:10.1021/pr0500962 · Cited by 86 · see citing works

International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values.

Solberg, H. E., & Petitclerc, C. (1988) · PubMed · Cited by 79 · see citing works

Effect of Posture on Serum Lipids

Tan, M. H., WILMSHURST, E. G., Gleason, R. E., & Soeldner, J. S. (1973) · New England Journal of Medicine · doi:10.1056/nejm197308232890808 · Cited by 74 · see citing works

Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin‐2 receptor α levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma

Sedlaczek, P., Frydecka, I., Gabryś, M. S., van Dalen, A., EINARSSON, R., & Harlozinska, A. (2002) · Cancer · doi:10.1002/cncr.10917 · Cited by 69 · see citing works

Neoplastic transformation: the contrasting stability of human and mouse cells.

Holliday, R. (1996) · PubMed · Cited by 63 · see citing works

DNA microarrays in breast cancer: the promise of personalised medicine

Ramaswamy, S., & Perou, C. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13322-3 · Cited by 58 · see citing works

Application of Bayes's theorem to results of quantitative clinical chemical determinations.

van der Helm, H. J., & Hische, E. A. (1979) · Clinical Chemistry · doi:10.1093/clinchem/25.6.985 · Cited by 47 · see citing works

The New European Directive on in vitro Diagnostics

Dati, F. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.196 · Cited by 45 · see citing works

Quantitative liquid chromatographic–tandem mass spectrometric determination of orlistat in plasma with a quadrupole ion trap

Wieboldt, R., Campbell, D. A., & Henion, J. D. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00653-1 · Cited by 44 · see citing works

Protein Standardization IV: Value Transfer. Procedure for the Assignment of Serum Protein Values from a Reference Preparation to a Target Material

Blirup-Jensen, S., Johnson, A., & Larsen, M. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.176 · Cited by 43 · see citing works

Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases

R�schinger, W., Olgem�ller, B., Fingerhut, R., Liebl, B., & Roscher, A. A. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1356-y · Cited by 43 · see citing works

Vocabulary for use in measurement procedures and description of reference materials in laboratory medicine.

Dybkær, R. (1997) · PubMed · Cited by 42 · see citing works

Reevaluation of Serum-Plasma Differences in Total Cholesterol Concentration

Cloey, T. A. (1990) · JAMA · doi:10.1001/jama.1990.03440200092029 · Cited by 41 · see citing works

Measurement of enkephalin peptides in canine brain regions, teeth, and cerebrospinal fluid with high-performance liquid chromatography and mass spectrometry

Desiderio, D. M., Kai, M., Tanzer, F. S., Trimble, J. W., & Wakelyn, C. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)89046-4 · Cited by 37 · see citing works

Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system

Tiller, P. R., Cunniff, J., Land, A. P., Schwartz, J. C., Jardine, I., Wakefield, M. R., Lopez, L. L., Newton, J. F., Burton, R., Folk, B. M., et al. (1997) · Journal of Chromatography A · doi:10.1016/s0021-9673(97)00147-7 · Cited by 30 · see citing works

Unraveling human cancer in the mouse: recent refinements to modeling and analysis

Resor, L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.669 · Cited by 23 · see citing works

College of American Pathologists Conference XXIII on matrix effects and accuracy assessment in clinical chemistry: introduction.

Miller, W. G., & Hw, K. (1993) · PubMed · Cited by 21 · see citing works

Medical Device Amendments of 1976

Greenberg, R. B. (1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.12.1308 · Cited by 21 · see citing works

Commutability of the CRM 470 C-Reactive Protein Value in the Dade Behring N High Sensitivity CRP Assay

JOHNSON, A. M., Ledue, T. B., & Collins, M. F. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.029 · Cited by 9 · see citing works

Standardization activities for harmonization of test results

Dati, F., & Brand, B. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00250-3 · Cited by 8 · see citing works

The role of off-line mass spectrometry in nuclear fission

Laeter, J. R. D. (1996) · Mass Spectrometry Reviews · doi:10.1002/(sici)1098-2787(1996)15:4 · Cited by 5 · see citing works

Biological variability in the concentration of serum lipids: sources, meta-analysis, estimation, and minimization by relative range measurements.

Gr, C., Sj, S., Gl, M., Ej, S., & Magid, E. (1995) · PubMed · Cited by 5 · see citing works

Circulating microRNAs as stable blood-based markers for cancer detection

Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · see citing works

Mass-spectrometric exploration of proteome structure and function

Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334 · see citing works

Protein Analysis by Shotgun/Bottom-up Proteomics

Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews · doi:10.1021/cr3003533 · Cited by 1,491 · see citing works

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury

KASHANI, K. B., Al-Khafaji, A. H., Ardiles, T., Artigas, A., Bagshaw, S. M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C. M., Chawla, L. S., et al. (2013) · Critical Care · doi:10.1186/cc12503 · Cited by 1,365 · see citing works

Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302 · see citing works

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037 · see citing works

Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules

Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 981 · see citing works

Revisiting biomarker discovery by plasma proteomics

Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917 · see citing works

Statistical strategies for avoiding false discoveries in metabolomics and related experiments

Broadhurst, D., & Kell, D. B. (2006) · Metabolomics · doi:10.1007/s11306-006-0037-z · Cited by 819 · see citing works

Biomarkers of Acute Kidney Injury

Vaidya, V. S., Ferguson, M. A., & Bonventre, J. V. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094615 · Cited by 741 · see citing works

Aptamer-Based Detection of Circulating Targets for Precision Medicine

Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C. J., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 704 · see citing works

Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution

Keshishian, H., Addona, T. A., Burgess, M. W., Kuhn, E. W., & Carr, S. A. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700354-mcp200 · Cited by 684 · see citing works

Exosomes in bodily fluids are a highly stable resource of disease biomarkers

Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400114 · Cited by 587 · see citing works

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C., Domon, B., Deutsch, E. W., Grant, R. P., Hoofnagle, A. N., Hüttenhain, R., Koomen, J. M., et al. (2014) · Molecular &amp; Cellular Proteomics · doi:10.1074/mcp.m113.036095 · Cited by 561 · see citing works

Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry

Tabb, D. L., Vega-Montoto, L., Rudnick, P. A., Variyath, A. M., Ham, A.-J. L., Bunk, D. M., Kilpatrick, L. E., Billheimer, D. D., Blackman, R. K., Cardasis, H. L., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr9006365 · Cited by 551 · see citing works

The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum

Anderson, N. L. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126706 · Cited by 564 · see citing works

Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues

Lee, J. H., Daugharthy, E. R., Scheiman, J., Kalhor, R., Ferrante, T. C., Terry, R., Turczyk, B. M., Yang, J. L., Lee, H. S., Aach, J., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2014.191 · Cited by 529 · see citing works

Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers

Zen, K., & Zhang, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 505 · see citing works

Paxdb, a database of protein abundance averages across all three domains of life

Wang, M., Weiss, M., Simonovic, M., Haertinger, G., Schrimpf, S. P., Hengartner, M. O., & von Mering, C. (2012) · Molecular &amp; Cellular Proteomics · doi:10.1074/mcp.o111.014704 · Cited by 466 · see citing works

Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

Gillette, M. A., & Carr, S. A. (2012) · Nature Methods · doi:10.1038/nmeth.2309 · Cited by 497 · see citing works

Aptamer/AuNP Biosensor for Colorimetric Profiling of Exosomal Proteins

Jiang, Y. Y., Shi, M., Liu, Y., Wan, S., Cui, C., Zhang, L., & Tan, W. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201703807 · Cited by 486 · see citing works

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

Prensner, J. R., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003180 · Cited by 470 · see citing works

The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing

Wilson, D. H., Rissin, D. M., Kan, C. W., Fournier, D. R., Piech, T., Campbell, T. G., Meyer, R. E., Fishburn, M. W., Cabrera, C., Patel, P. P., et al. (2015) · SLAS TECHNOLOGY · doi:10.1177/2211068215589580 · Cited by 470 · see citing works

‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics

Horgan, R., & Kenny, L. C. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.3.189.27672 · Cited by 461 · see citing works

Urine in Clinical Proteomics

Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J., & Schanstra, J. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800001-mcp200 · Cited by 446 · see citing works

Isotope-labeled Protein Standards

Brun, V., Dupuis, A., Adrait, A., Marcellin, M., Thomas, D. Y., Court, M., Vandenesch, F., & Garin, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700163-mcp200 · Cited by 443 · see citing works

Mass spectrometry-based proteomics: existing capabilities and future directions

Angel, T. E., Aryal, U. K., Hengel, S. M., Baker, E. S., Kelly, R., Robinson, E. W., & Smith, R. D. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15331a · Cited by 443 · see citing works

Proteomics: a pragmatic perspective

Mallick, P., & Küster, B. (2010) · Nature Biotechnology · doi:10.1038/nbt.1658 · Cited by 428 · see citing works

Diagnostics of Inflammatory Bowel Disease

Nikolaus, S., & Schreiber, S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.001 · Cited by 430 · see citing works

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Füzéry, A. K., Levin, J. D., Chan, M. M., & Chan, D. W. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-13 · Cited by 428 · see citing works

Challenges and emergent solutions for LC‐MS/MS based untargeted metabolomics in diseases

Liang, C., Lu, H., & Lee, Y. H. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21562 · Cited by 419 · see citing works

Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry

Rauniyar, N. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226120 · Cited by 406 · see citing works

Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications

Pan, S., Aebersold, R. H., Chen, R., Rush, A. J., Goodlett, D. R., McIntosh, M. W., Zhang, J., & Brentnall, T. A. (2008) · Journal of Proteome Research · doi:10.1021/pr800538n · Cited by 393 · see citing works

Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics

Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390 · see citing works

Targeted proteomic strategy for clinical biomarker discovery

Schiess, R., Wollscheid, B., & Aebersold, R. H. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.12.001 · Cited by 369 · see citing works

A targeted proteomics–based pipeline for verification of biomarkers in plasma

Whiteaker, J. R., Lin, C., Kennedy, J. J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1900 · Cited by 365 · see citing works

High-sensitivity nanosensors for biomarker detection

Swierczewska, M., Liu, G., Lee, S., & Chen, X. S. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15238f · Cited by 363 · see citing works

High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites

Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K., Krek, W., Aebersold, R. H., & Domon, B. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700132-mcp200 · Cited by 361 · see citing works

A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of This Field

Dupree, E. J., Jayathirtha, M., Yorkey, H., Mihăşan, M., Petre, B. A., & Darie, C. C. (2020) · Proteomes · doi:10.3390/proteomes8030014 · Cited by 357 · see citing works

Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans

Vaidya, V. S., Waikar, S. S., Ferguson, M. A., Collings, F. B., Sunderland, K., Gioules, C. J., Bradwin, G., Matsouaka, R., Betensky, R. A., Curhan, G. C., et al. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00053.x · Cited by 339 · see citing works

Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

Mischak, H., Allmaier, G. M., Apweiler, R., Attwood, T. K., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam‐Rudloff, E., Capasso, G., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001249 · Cited by 333 · see citing works

An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers

Whiteaker, J. R., Zhao, L., Anderson, L., & Paulovich, A. G. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900254-mcp200 · Cited by 323 · see citing works

Biomarkers of nephrotoxic acute kidney injury

Ferguson, M. A., Vaidya, V. S., & Bonventre, J. V. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.024 · Cited by 323 · see citing works

Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection

Steckl, A. J., & Ray, P. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00726 · Cited by 319 · see citing works

Biomarkers and surrogate end points—the challenge of statistical validation

Buyse, M. E., Sargent, D. J., Grothey, A. F., Matheson, A., & de Gramont, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.43 · Cited by 316 · see citing works

Isotope dilution strategies for absolute quantitative proteomics

Brun, V., Masselon, C., Garin, J., & Dupuis, A. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.03.007 · Cited by 314 · see citing works

Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry

Hoofnagle, A. N., Becker, J. O., Wener, M. H., & Heinecke, J. W. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109652 · Cited by 314 · see citing works

The leaf ionome as a multivariable system to detect a plant's physiological status

Baxter, I. R., Vitek, O., Lahner, B., Muthukumar, B., Borghi, M., Morrissey, J., Guerinot, M. L., & Salt, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804175105 · Cited by 305 · see citing works

Clinical proteomics: A need to define the field and to begin to set adequate standards

Mischak, H., Apweiler, R., Banks, R. E., Conaway, M. R., Coon, J. J., Dominiczak, A. F., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., et al. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200600771 · Cited by 307 · see citing works

Early Detection of Ovarian Cancer

Badgwell, D. B., & Bast, R. C. (2007) · Disease Markers · doi:10.1155/2007/309382 · Cited by 298 · see citing works

Prediction of high-responding peptides for targeted protein assays by mass spectrometry

Fusaro, V. A., Mani, D. R., Mesirov, J. P., & Carr, S. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1524 · Cited by 293 · see citing works

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

Hathout, Y., Brody, E. N., Clemens, P. R., Cripe, L. H., DeLisle, R. K., Furlong, P., Gordish‐Dressman, H., Hache, L. P., Henricson, E., Hoffman, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507719112 · Cited by 291 · see citing works

Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives

Gracia‐Lor, E., Castiglioni, S., Bade, R., Béen, F. M., Castrignanò, E., Covaci, A., González‐Mariño, I., Hapeshi, E., Kasprzyk‐Hordern, B., Kinyua, J., et al. (2016) · Environment International · doi:10.1016/j.envint.2016.12.016 · Cited by 293 · see citing works

Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution

Keshishian, H., Addona, T. A., Burgess, M. W., Mani, D. R., Shi, X. D., Kuhn, E. W., Sabatine, M. S., Gerszten, R. E., & Carr, S. A. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900140-mcp200 · Cited by 286 · see citing works

Selected reaction monitoring applied to proteomics

Gallien, S., Duriez, E., & Domon, B. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1895 · Cited by 285 · see citing works

Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications

Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 282 · see citing works

Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation

Nakayasu, E. S., Gritsenko, M., Piehowski, P., Gao, Y., Orton, D., Schepmoes, A., Fillmore, T., Frohnert, B. I., Rewers, M., Krischer, J. P., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00566-6 · Cited by 281 · see citing works

Quantitative proteomics: challenges and opportunities in basic and applied research

Schubert, O. T., Röst, H. L., Collins, B. C., Rosenberger, G., & Aebersold, R. H. (2017) · Nature Protocols · doi:10.1038/nprot.2017.040 · Cited by 276 · see citing works

Mass Spectrometry Based Glycoproteomics—From a Proteomics Perspective

Pan, S., Chen, R., Aebersold, R. H., & Brentnall, T. A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r110.003251 · Cited by 268 · see citing works

Protein-targeted corona phase molecular recognition

Bisker, G., Dong, J. I., Park, H. D., Iverson, N. M., Ahn, J., Nelson, J. T., Landry, M. P., Kruss, S., & Strano, M. S. (2016) · Nature Communications · doi:10.1038/ncomms10241 · Cited by 258 · see citing works

Nucleic acid aptamers in cancer research, diagnosis and therapy

Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 266 · see citing works

Rapid electrochemical detection on a mobile phone

Lillehoj, P. B., Huang, M.-C., Truong, N., & Ho, C. (2013) · Lab on a Chip · doi:10.1039/c3lc50306b · Cited by 259 · see citing works

Statistical Design of Quantitative Mass Spectrometry-Based Proteomic Experiments

Oberg, A. L., & Olga Vitek, A. (2009) · Journal of Proteome Research · doi:10.1021/pr8010099 · Cited by 258 · see citing works

Body fluid biomarkers in multiple sclerosis

Comabella, M., & Montalbán, X. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70233-3 · Cited by 253 · see citing works

Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma

Kim, K., Kim, M., Kim, D. W., Kim, S. Y., Park, S., & Park, C. B. (2020) · Nature Communications · doi:10.1038/s41467-019-13901-z · Cited by 258 · see citing works

Mass-Spectrometry-Based Molecular Characterization of Extracellular Vesicles: Lipidomics and Proteomics

Kreimer, S. D., Belov, A. M., Ghiran, I. C., Murthy, S. K., Frank, D. A., & Ivanov, A. R. (2015) · Journal of Proteome Research · doi:10.1021/pr501279t · Cited by 250 · see citing works

Proteomics technologies for cancer liquid biopsies

Ding, Z., Wang, N., Ji, N., & Chen, Z. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01526-8 · Cited by 250 · see citing works

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

Addona, T. A., Shi, X. D., Keshishian, H., Mani, D. R., Burgess, M. W., Gillette, M. A., Clauser, K. R., Shen, D., Lewis, G. D., Farrell, L. A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1899 · Cited by 249 · see citing works

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma

Abbatiello, S. E., Schilling, B., Mani, D. R., Zimmerman, L. J., Hall, S. C., MacLean, B., Albertolle, M., Allen, S., Burgess, M., Cusack, M. P., et al. (2015) · Molecular &amp; Cellular Proteomics · doi:10.1074/mcp.m114.047050 · Cited by 215 · see citing works

Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics

Hüttenhain, R., Soste, M., Selevsek, N., Röst, H. L., Sethi, A., Carapito, C., Farrah, T., Deutsch, E. W., Kusebauch, U., Moritz, R. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003989 · Cited by 245 · see citing works

Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry

Kuhn, E. W., Addona, T. A., Keshishian, H., Burgess, M. W., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., & Carr, S. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.123935 · Cited by 247 · see citing works

Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics

Shi, T., Su, D. G. T., Liu, T., Tang, K., Camp, D., Qian, W., & Smith, R. D. (2012) · PROTEOMICS · doi:10.1002/pmic.201100436 · Cited by 245 · see citing works

Validation of Analytic Methods for Biomarkers Used in Drug Development

Chau, C. H., Rixe, O., McLeod, H. L., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4535 · Cited by 241 · see citing works

Mass spectrometry based biomarker discovery, verification, and validation — Quality assurance and control of protein biomarker assays

Parker, C. E., & Borchers, C. H. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.006 · Cited by 238 · see citing works

Tears as a source of biomarkers for ocular and systemic diseases

Hohenstein-Blaul, N. V. T. U., Funke, S., & Grus, F. H. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.07.015 · Cited by 236 · see citing works

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., & Wang, P. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780174 · Cited by 229 · see citing works

Surface plasmon resonance applications in clinical analysis

Mariani, S., & Minunni, M. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7647-5 · Cited by 231 · see citing works

Stable-Isotope Dilution LC–MS for Quantitative Biomarker Analysis

Ciccimaro, E., & Blair, I. A. (2010) · Bioanalysis · doi:10.4155/bio.09.185 · Cited by 227 · see citing works

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

Shi, T., Fillmore, T., Sun, X., Zhao, R., Schepmoes, A., Hossain, M., Xie, F., Wu, S., Kim, J., Jones, N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204366109 · Cited by 220 · see citing works

Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury

Keshishian, H., Burgess, M. W., Gillette, M. A., Mertins, P., Clauser, K. R., Mani, D. R., Kuhn, E. W., Farrell, L. A., Gerszten, R. E., & Carr, S. A. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.046813 · Cited by 222 · see citing works

Breaking the concentration limit of optical single-molecule detection

Holzmeister, P., Acuna, G. P., Grohmann, D., & Tinnefeld, P. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60207a · Cited by 219 · see citing works

Comparison of Multiplex Immunoassay Platforms

Fu, Q., Zhu, J., & Eyk, J. E. V. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.135087 · Cited by 217 · see citing works

Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung CancerPreprint

Ostroff, R. M., Bigbee, W. L., Franklin, W. A., Gold, L., Mehan, M., Miller, Y. E., Pass, H. I., Rom, W. N., Siegfried, J. M., Stewart, A., et al. (2010) · Nature Precedings · doi:10.1371/journal.pone.0015003 · Cited by 213 · see citing works

Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

Huang, D. T., Weissfeld, L. A., Kellum, J. A., Yealy, D. M., Kong, L., Martino, M., & Angus, D. C. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.01.003 · Cited by 212 · see citing works

Colorimetric Split G-Quadruplex Probes for Nucleic Acid Sensing: Improving Reconstituted DNAzyme’s Catalytic Efficiency via Probe Remodeling

Nakayama, S., & Sintim, H. O. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902951b · Cited by 204 · see citing works

Automated Detection of Inaccurate and Imprecise Transitions in Peptide Quantification by Multiple Reaction Monitoring Mass Spectrometry

Abbatiello, S. E., Mani, D. R., Keshishian, H., & Carr, S. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.138420 · Cited by 198 · see citing works

Aptamer-Facilitated Biomarker Discovery (AptaBiD)

Berezovski, M. V., Lechmann, M., Musheev, M. U., Mak, T. W., & Krylov, S. N. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801951p · Cited by 198 · see citing works

Top-Down Quantitative Proteomics Identified Phosphorylation of Cardiac Troponin I as a Candidate Biomarker for Chronic Heart Failure

Zhang, J., Guy, M. J., Norman, H. S., Chen, Y.-C., Xu, Q., Dong, X., Guner, H., Wang, S., Kohmoto, T., Young, K. H., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200258m · Cited by 194 · see citing works

Modules, networks and systems medicine for understanding disease and aiding diagnosis

Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0082-6 · Cited by 194 · see citing works

Novel Strategies to Address the Challenges in Top-Down Proteomics

Melby, J. A., Roberts, D. S., Larson, E. J., Brown, K. A., Bayne, E. F., Jin, S., & Ge, Y. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.1c00099 · Cited by 191 · see citing works

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

Cima, I., Schiess, R., Wild, P. J., Kaelin, M., Schüffler, P. J., Lange, V., Picotti, P., Ossola, R., Templeton, A. J., Schubert, O. T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013699108 · Cited by 190 · see citing works

Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy

Qian, W.-J., Kaleta, D. T., Petritis, B. O., Jiang, H., Liu, T., Zhang, X., Mottaz, H. M., Varnum, S. M., Camp, D. G., Huang, L., et al. (2008) · Molecular &amp; Cellular Proteomics · doi:10.1074/mcp.m800008-mcp200 · Cited by 208 · see citing works

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

Kennedy, J. J., Abbatiello, S. E., Kim, K., Yan, P., Whiteaker, J. R., Lin, C., Kim, J. S., Zhang, Y., Wang, X., Ivey, R. G., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2763 · Cited by 184 · see citing works

Applications of targeted proteomics in systems biology and translational medicine

Ebhardt, H. A., Root, A., Sander, C., & Aebersold, R. (2015) · PROTEOMICS · doi:10.1002/pmic.201500004 · Cited by 184 · see citing works

Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts

Li, J., Zhu, X., & Chen, J. Y. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000450 · Cited by 185 · see citing works

Lipidomic profiling of human serum enables detection of pancreatic cancer

Wolrab, D., Jirásko, R., Cífková, E., Höring, M., Ding, M., Chocholoušková, M., Peterka, O., Idkowiak, J., Hrnčiarová, T., Kuchař, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27765-9 · Cited by 185 · see citing works

Defining Salivary Biomarkers Using Mass Spectrometry-Based Proteomics: A Systematic Review

Al-Tarawneh, S., Border, M. B., Dibble, C. F., & Bencharit, S. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0134 · Cited by 184 · see citing works

The application of statistical methods using VOCs to identify patients with lung cancer

Ulanowska, A., Kowalkowski, T., Trawińska, E., & Buszewski, B. (2011) · Journal of Breath Research · doi:10.1088/1752-7155/5/4/046008 · Cited by 183 · see citing works

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

Kuhn, E. W., Whiteaker, J. R., Mani, D. R., Jackson, A., Zhao, L., Pope, M. E., SMITH, D. S. H., Rivera, K. D., Anderson, N. L., Skates, S. J., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013854 · Cited by 183 · see citing works

Mass Spectrometry-Based Proteomics in Preclinical Drug Discovery

Schirle, M., Bantscheff, M., & Küster, B. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.002 · Cited by 178 · see citing works

Validation of Candidate Protein Biomarkers

Pavlou, M. P., & Diamandis, E. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00022-7 · Cited by 5 · see citing works

Biomarker discovery and clinical proteomics

Silberring, J., & Ciborowski, P. S. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.11.007 · Cited by 101 · see citing works

Streamlining biomarker discovery

Latterich, M., & Schnitzer, J. E. (2011) · Nature Biotechnology · doi:10.1038/nbt.1917 · Cited by 14 · see citing works

Toward an integrated pipeline for protein biomarker development

Drabovich, A. P., Martínez‐Morillo, E., & Diamandis, E. P. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.09.006 · Cited by 83 · see citing works

Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?

Carr, S. A., & Anderson, L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.114686 · Cited by 139 · see citing works